Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Meropenem
Drug ID BADD_D01393
Description Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death. In August 2017, a combination antibacterial therapy under the market name vabomere was approved for treatment of adult patients with complicated urinary tract infections (cUTI). Vabomere consists of meropenem and [DB12107] and is intravenously admininstered. The treatment aims to resolve infection-related symptoms and achieve negative urine culture, where the infections are proven or strongly suspected to be caused by susceptible bacteria.
Indications and Usage For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: complicated skin and skin structure infections due to Staphylococcus aureus (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis and Peptostreptococcus species; complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species. Also for use in the treatment of bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (b-lactamase and non-b-lactamase-producing isolates), and Neisseria meningitidis.
Marketing Status Prescription; Discontinued
ATC Code J01DH02
DrugBank ID DB00760
KEGG ID D02222
MeSH ID D000077731
PubChem ID 441130
TTD Drug ID D0O5FY
NDC Product Code 44567-146; 38217-0021; 70594-075; 72572-415; 70121-1453; 44567-401; 0781-3000; 70278-104; 0409-1390; 63323-508; 63323-507; 70594-076; 70121-1454; 70278-103; 0409-1391; 68083-146; 55150-208; 72572-416; 44647-032; 44567-145; 0781-3098; 52946-0839; 44567-400; 44647-033; 55150-207; 68001-324; 0069-0314; 38217-0020; 68083-147; 68001-447; 68001-323; 68001-446
Synonyms Meropenem | 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid | Merrem | Ronem | Penem | SM 7338 | SM-7338 | SM7338
Chemical Information
Molecular Formula C17H25N3O5S
CAS Registry Number 96036-03-2
SMILES CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Flatulence07.01.04.002--
Fluid overload14.05.06.001; 02.05.04.0040.000426%Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.0250.000319%
Fungal infection11.03.05.0010.000426%Not Available
Gait disturbance17.02.05.016; 08.01.02.002--
Gamma-glutamyltransferase increased13.03.01.011--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal haemorrhage07.12.02.001; 24.07.02.009--Not Available
Gastrointestinal pain07.01.05.005--
Generalised tonic-clonic seizure17.12.01.0020.000426%Not Available
Glossitis07.14.01.001--Not Available
Granulocytopenia01.02.03.0030.000213%Not Available
Haematocrit decreased13.01.05.001--Not Available
Haematuria24.07.01.047; 20.02.01.0060.000213%
Haemoglobin13.01.05.018--Not Available
Haemoglobin decreased13.01.05.003--Not Available
Haemolytic anaemia01.06.03.002--Not Available
Haemorrhage intracranial24.07.04.003; 17.08.01.0080.000056%
Hallucination19.10.02.002--
Headache17.14.01.001--
Heart rate increased13.14.04.0020.000532%Not Available
Hepatic encephalopathy17.13.01.003; 09.01.03.0060.000426%Not Available
Hepatic failure09.01.03.0020.000194%
Hepatic function abnormal09.01.02.0010.001277%Not Available
Hepatitis09.01.07.0040.000745%Not Available
Hepatitis cholestatic09.01.01.0020.000319%Not Available
Hepatocellular injury09.01.07.0080.000745%Not Available
Hepatotoxicity12.03.01.008; 09.01.07.0090.000319%Not Available
Hyperbilirubinaemia14.11.01.010; 09.01.01.003; 01.06.04.0030.000213%Not Available
Hyperhidrosis23.02.03.004; 08.01.03.028--
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 11 Pages